Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

BCAT1 antibody

BCAT1 Reactivity: Human, Mouse, Dog WB, IHC Host: Mouse Monoclonal 3F5 unconjugated
Catalog No. ABIN2716546
  • Target See all BCAT1 Antibodies
    BCAT1 (Branched Chain Amino-Acid Transaminase 1, Cytosolic (BCAT1))
    Reactivity
    • 44
    • 24
    • 20
    • 5
    • 4
    • 4
    • 3
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    Human, Mouse, Dog
    Host
    • 61
    • 5
    Mouse
    Clonality
    • 63
    • 3
    Monoclonal
    Conjugate
    • 29
    • 5
    • 5
    • 5
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    This BCAT1 antibody is un-conjugated
    Application
    • 49
    • 29
    • 23
    • 14
    • 13
    • 13
    • 9
    • 3
    • 3
    • 3
    • 2
    • 1
    • 1
    Western Blotting (WB), Immunohistochemistry (IHC)
    Characteristics
    Homo sapiens branched chain amino-acid transaminase 1, cytosolic (BCAT1), transcript variant 1
    Purification
    Purified from mouse ascites fluids by affinity chromatography
    Immunogen
    Full length human recombinant protein of human BCAT1(NP_005495) produced in HEK293T cell.
    Clone
    3F5
    Isotype
    IgG2a
    Top Product
    Discover our top product BCAT1 Primary Antibody
  • Application Notes
    WB 1:500~2000, IHC 1:150,
    Comment

    The concentration of the product may vary between diferrent lots.

    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    0.5-1.0 mg/mL
    Buffer
    PBS (PH 7.3) containing 1 % BSA, 50 % glycerol and 0.02 % sodium azide.
    Preservative
    Sodium azide
    Precaution of Use
    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Storage
    -20 °C
  • Cho, Jeon, Park, Park, Kang, Choi: "BCAT1 is a New MR Imaging-related Biomarker for Prognosis Prediction in IDH1-wildtype Glioblastoma Patients." in: Scientific reports, Vol. 7, Issue 1, pp. 17740, (2017) (PubMed).

    Hattori, Tsunoda, Konuma, Kobayashi, Nagy, Glushka, Tayyari, McSkimming, Kannan, Tojo, Edison, Ito: "Cancer progression by reprogrammed BCAA metabolism in myeloid leukaemia." in: Nature, Vol. 545, Issue 7655, pp. 500-504, (2017) (PubMed).

  • Target
    BCAT1 (Branched Chain Amino-Acid Transaminase 1, Cytosolic (BCAT1))
    Alternative Name
    BCAT1 (BCAT1 Products)
    Synonyms
    fj66g02 antibody, zgc:73157 antibody, wu:fj66g02 antibody, Bcatc antibody, BCATC antibody, BCT1 antibody, ECA39 antibody, MECA39 antibody, PNAS121 antibody, PP18 antibody, BCATc antibody, Eca39 antibody, branched chain amino-acid transaminase 1, cytosolic antibody, branched chain amino acid transaminase 1 antibody, branched chain amino-acid transaminase 1, cytosolic L homeolog antibody, branched chain aminotransferase 1, cytosolic antibody, bcat1 antibody, BCAT1 antibody, bcat1.L antibody, Bcat1 antibody
    Background
    This gene encodes the cytosolic form of the enzyme branched-chain amino acid transaminase. This enzyme catalyzes the reversible transamination of branched-chain alpha-keto acids to branched-chain L-amino acids essential for cell growth. Two different clinical disorders have been attributed to a defect of branched-chain amino acid transamination: hypervalinemia and hyperleucine-isoleucinemia. As there is also a gene encoding a mitochondrial form of this enzyme, mutations in either gene may contribute to these disorders. Alternatively spliced transcript variants have been described.
    Molecular Weight
    42.8 kDa
    Gene ID
    586
    NCBI Accession
    NM_005504
    HGNC
    586
You are here:
Support